Interested in cell-based assays to advance your COVID-19 research?

With the D300e Digital Dispenser potential drugs can be added in simple dose response curves or drug combinations to your cells to investigate their effect on virus infected cells.

D300e Digital Dispenser replaces manual serial dilution and will make your research faster and more efficient.

The easy way to test potential drugs against Coronavirus

The D300e Digital Dispenser automates the dispensing of drugs into your assay plate for easy set-up of dose response curves. Drugs are added in stock concentration to every well to establish simple titrations, drug combinations or randomized layouts in a fraction of time compared to manual serial dilution.

The contact-free, direct dispensing technology delivers fluids in thousands of picoliter droplets eliminating artefacts from solvents like DMSO and supports miniaturization to test more drugs or conditions with the same amount of cells.

Figure 1: Shows HeLa cells visualized with fluorescence imaging to assess cell viability (green: viable; red: dead) 6 h after addition of 1 µl DMSO (100%) via (A) manual pipetting and (B) the D300e. (C) Plate layout examples of a 384 well plate with D300e Control software.